Yrina earned her PhD from the Hebrew University of Jerusalem. She completed her post-doctoral training in molecular immunology at National Institutes of Health in the laboratory of Dr. Warren Leonard, where she published several papers and reviews in high profile peer-reviewed journals. She is a recipient of the Lenfant Biomedical Award from NHLBI, NIH for outstanding research. Her research is focused on elucidating molecular mechanisms of immunological responses.
PhD: Hebrew University of Jerusalem, Israel, 2005.
Post-Doc Fellowship: NHLBI/National Institutes of Health, Bethesda, MD, 2005-2011.
Research Associate: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2012-2013.
Research Instructor: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2013-present.
Immunology
Allergen-specific mRNA-lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice. Journal of Clinical Investigation. 2025; 135(21).
TH2 cell compensatory effect following benralizumab treatment for eosinophilic gastritis. Journal of Allergy and Clinical Immunology. 2024; 154(5):1325-1332.e2.
TSLP shapes the pathogenic responses of memory CD4+ T cells in eosinophilic esophagitis. Science Signaling. 2023; 16(802):eadg6360.
The minichromosome maintenance complex drives esophageal basal zone hyperplasia. JCI Insight. 2023; 8(17).
Local type 2 immunity in eosinophilic gastritis. Journal of Allergy and Clinical Immunology. 2023; 152(1):136-144.
Environmental allergens trigger type 2 inflammation through ripoptosome activation. Nature Immunology. 2021; 22(10):1316-1326.
Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis. Journal of Clinical Investigation. 2019; 129(5):2014-2028.
TSLP signaling in CD4+ T cells programs a pathogenic T helper 2 cell state. Science Signaling. 2018; 11(521).
Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8. Nature Immunology. 2015; 16(12):1274-1281.
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS ONE. 2015; 10(4):e0122198.
Yrina Rochman, PhD, Marc E. Rothenberg, MD, PhD9/23/2025
Yrina Rochman, PhD, Marc E. Rothenberg, MD, PhD9/12/2023